600351 亚宝药业
已收盘 08-17 15:00:00
资讯
新帖
简况
每周股票复盘：亚宝药业（600351）将召开2026年半年度业绩说明会
证券之星 · 08-16 03:19
每周股票复盘：亚宝药业（600351）将召开2026年半年度业绩说明会
股市必读：亚宝药业新发布《亚宝药业集团股份有限公司关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告》
证券之星 · 08-14
股市必读：亚宝药业新发布《亚宝药业集团股份有限公司关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告》
亚宝药业（600351）披露回购股份事项前十名股东持股情况，8月12日股价上涨0.29%
证券之星 · 08-12
亚宝药业（600351）披露回购股份事项前十名股东持股情况，8月12日股价上涨0.29%
股市必读：亚宝药业新发布《亚宝药业集团股份有限公司关于召开2026年半年度业绩说明会的公告》
证券之星 · 08-12
股市必读：亚宝药业新发布《亚宝药业集团股份有限公司关于召开2026年半年度业绩说明会的公告》
亚宝药业（600351）披露2026年半年度业绩说明会公告，8月10日股价上涨2.05%
证券之星 · 08-10
亚宝药业（600351）披露2026年半年度业绩说明会公告，8月10日股价上涨2.05%
股市必读：亚宝药业新发布《亚宝药业集团股份有限公司2026年第三次临时股东会会议资料》
证券之星 · 08-10
股市必读：亚宝药业新发布《亚宝药业集团股份有限公司2026年第三次临时股东会会议资料》
每周股票复盘：亚宝药业（600351）拟回购1-2亿股份
证券之星 · 08-09
每周股票复盘：亚宝药业（600351）拟回购1-2亿股份
亚宝药业（600351）披露2026年中期利润分配及股份回购预案，8月6日股价下跌1.48%
证券之星 · 08-06
亚宝药业（600351）披露2026年中期利润分配及股份回购预案，8月6日股价下跌1.48%
股市必读：亚宝药业新发布《亚宝药业集团股份有限公司关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告》
证券之星 · 08-06
股市必读：亚宝药业新发布《亚宝药业集团股份有限公司关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告》
亚宝药业（600351）披露回购股份事项前十名股东持股情况，8月4日股价下跌0.43%
证券之星 · 08-04
亚宝药业（600351）披露回购股份事项前十名股东持股情况，8月4日股价下跌0.43%
8月3日亚宝药业涨6.80%，华富匠心明选一年持有混合A基金重仓该股
证券之星 · 08-03
8月3日亚宝药业涨6.80%，华富匠心明选一年持有混合A基金重仓该股
亚宝药业（600351）2026年中报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 08-02
亚宝药业（600351）2026年中报简析：营收净利润同比双双增长，盈利能力上升
每周股票复盘：亚宝药业（600351）Q2收入增9.15%，拟每10股派2元
证券之星 · 08-02
每周股票复盘：亚宝药业（600351）Q2收入增9.15%，拟每10股派2元
亚宝药业(600351)6月30日股东户数4.78万户，较上期减少6.47%
证券之星 · 07-31
亚宝药业(600351)6月30日股东户数4.78万户，较上期减少6.47%
亚宝药业最新公告：全资子公司获盐酸左西替利嗪口服溶液药品注册证书
证券之星 · 07-31
亚宝药业最新公告：全资子公司获盐酸左西替利嗪口服溶液药品注册证书
亚宝药业(600351.SH)拟1亿元至2亿元回购股份
智通财经 · 07-31
亚宝药业(600351.SH)拟1亿元至2亿元回购股份
每周股票复盘：亚宝药业（600351）获克立硼罗软膏注册证
证券之星 · 07-05
每周股票复盘：亚宝药业（600351）获克立硼罗软膏注册证
亚宝药业(600351.SH)：取得克立硼罗软膏药品注册证书
智通财经网 · 07-02
亚宝药业(600351.SH)：取得克立硼罗软膏药品注册证书
每周股票复盘：亚宝药业（600351）东莨菪碱透皮贴片获临床试验批准
证券之星 · 06-28
每周股票复盘：亚宝药业（600351）东莨菪碱透皮贴片获临床试验批准
亚宝药业(600351.SH)：东莨菪碱透皮贴片获批开展临床试验
智通财经 · 06-25
亚宝药业(600351.SH)：东莨菪碱透皮贴片获批开展临床试验
加载更多
公司概况
公司名称：
亚宝药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2002-09-26
主营业务：
亚宝药业集团股份有限公司的主营业务是药品及大健康产品的研发、生产和销售。公司的主要产品是丁桂儿脐贴、薏芽健脾凝胶、儿童清咽解热口服液、甲钴胺片、盐酸倍他司汀注射液、红花注射液、硝苯地平缓释片、唯源素、唯源泰、唯源全。
发行价格：
4.80
{"stockData":{"symbol":"600351","market":"SH","secType":"STK","nameCN":"亚宝药业","latestPrice":7.16,"timestamp":1786950001000,"preClose":6.97,"halted":0,"volume":51017280,"delay":0,"changeRate":0.0273,"floatShares":692000000,"shares":692000000,"eps":0.4671,"marketStatus":"已收盘","change":0.19,"latestTime":"08-17 15:00:00","open":6.98,"high":7.45,"low":6.78,"amount":363000000,"amplitude":0.0961,"askPrice":7.16,"askSize":1141,"bidPrice":7.15,"bidSize":651,"shortable":0,"etf":0,"ttmEps":0.4671,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787016600000},"marketStatusCode":5,"adr":0,"adjPreClose":6.97,"symbolType":"stock","openAndCloseTimeList":[[1786930200000,1786937400000],[1786942800000,1786950000000]],"highLimit":7.67,"lowLimit":6.27,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":692000046,"isCdr":false,"pbRate":1.76,"roa":"--","peRate":15.328623,"roe":"6.25%","epsLYR":0.46,"committee":-0.391736,"marketValue":4955000000,"turnoverRate":0.0737,"status":0,"floatMarketCap":4955000000},"requestUrl":"/m/hq/s/600351","defaultTab":"news","newsList":[{"id":"2659976176","title":"每周股票复盘：亚宝药业（600351）将召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2659976176","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659976176?lang=zh_cn&edition=full","pubTime":"2026-08-16 03:19","pubTimestamp":1786821549,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，亚宝药业报收于6.97元，较上周的6.82元上涨2.2%。本周关注点公司公告汇总：亚宝药业将于2026年8月18日召开半年度业绩说明会。公司公告汇总亚宝药业集团股份有限公司将于2026年8月18日14:00-15:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会，介绍公司半年度经营成果及财务状况。亚宝药业集团股份有限公司于2026年7月31日召开第十届董事会第二次会议，审议通过《关于以集中竞价交易方式回购股份方案的议案》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600000975.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600351","BK0096","BK0077","BK0201","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659952169","title":"股市必读：亚宝药业新发布《亚宝药业集团股份有限公司关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2659952169","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659952169?lang=zh_cn&edition=full","pubTime":"2026-08-14 01:00","pubTimestamp":1786640449,"startTime":"0","endTime":"0","summary":"公司公告汇总：亚宝药业于2026年8月13日公告回购股份事项对应的截至8月11日的前十大股东持股情况，山西亚宝投资集团有限公司以94,300,000股、占比13.63%位居第一。公司公告汇总亚宝药业集团股份有限公司关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告亚宝药业集团股份有限公司于2026年7月31日召开第十届董事会第二次会议，审议通过《关于以集中竞价交易方式回购股份方案的议案》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400000735.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","600351","BK0028","BK0077","BK0239","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658733739","title":"亚宝药业（600351）披露回购股份事项前十名股东持股情况，8月12日股价上涨0.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658733739","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658733739?lang=zh_cn&edition=full","pubTime":"2026-08-12 17:22","pubTimestamp":1786526556,"startTime":"0","endTime":"0","summary":"截至2026年8月12日收盘，亚宝药业报收于6.93元，较前一交易日上涨0.29%，最新总市值为47.96亿元。该股当日开盘6.91元，最高7.02元，最低6.83元，成交额达1.56亿元，换手率为3.26%。近日，亚宝药业集团股份有限公司发布《关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告》。前十名股东与前十名无限售条件股东名单一致，其中山西亚宝投资集团有限公司持股94,300,000股，占比13.63%，位居第一。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200029187.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600351","BK0239","BK0201","BK0096","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658695912","title":"股市必读：亚宝药业新发布《亚宝药业集团股份有限公司关于召开2026年半年度业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658695912","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658695912?lang=zh_cn&edition=full","pubTime":"2026-08-12 01:05","pubTimestamp":1786467915,"startTime":"0","endTime":"0","summary":"截至2026年8月11日收盘，亚宝药业报收于6.91元，下跌0.72%，换手率4.46%，成交量30.9万手，成交额2.15亿元。当日关注点交易信息汇总：8月11日主力资金净流出1680.26万元，占总成交额7.8%。公司公告汇总：亚宝药业将于2026年8月18日14:00-15:00召开2026年半年度业绩说明会，通过上证路演中心网络互动方式进行。投资者可于8月11日至8月17日16:00前通过上证路演中心网站或公司邮箱提交问题。说明会结束后可通过该平台查看会议内容。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200001392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600351","BK0096","BK0077","BK0201","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658324419","title":"亚宝药业（600351）披露2026年半年度业绩说明会公告，8月10日股价上涨2.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658324419","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658324419?lang=zh_cn&edition=full","pubTime":"2026-08-10 22:26","pubTimestamp":1786371993,"startTime":"0","endTime":"0","summary":"截至2026年8月10日收盘，亚宝药业报收于6.96元，较前一交易日上涨2.05%，最新总市值为48.16亿元。该股当日开盘6.8元，最高7.02元，最低6.75元，成交额达2.63亿元，换手率为5.51%。公告显示，公司将于2026年8月18日14:00-15:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会，介绍公司半年度经营成果及财务状况。投资者可于8月11日至8月17日16:00前通过上证路演中心网站或公司邮箱提交问题。说明会结束后可通过该平台查看会议内容。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000034324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0028","600351","BK0201","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658360608","title":"股市必读：亚宝药业新发布《亚宝药业集团股份有限公司2026年第三次临时股东会会议资料》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658360608","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658360608?lang=zh_cn&edition=full","pubTime":"2026-08-10 02:19","pubTimestamp":1786299550,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，亚宝药业报收于6.82元，上涨2.4%，换手率5.26%，成交量36.39万手，成交额2.45亿元。公司公告汇总：亚宝药业拟每10股派发现金红利2元（含税），并启动金额1亿至2亿元的股份回购，用于注销减资。公司公告汇总亚宝药业集团股份有限公司2026年第三次临时股东会会议资料亚宝药业召开2026年第三次临时股东会，审议2026年中期利润分配方案及以集中竞价交易方式回购股份的议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000001005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0077","BK0201","600351","BK0096","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658755166","title":"每周股票复盘：亚宝药业（600351）拟回购1-2亿股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2658755166","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658755166?lang=zh_cn&edition=full","pubTime":"2026-08-09 02:43","pubTimestamp":1786214590,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，亚宝药业报收于6.82元，较上周的6.47元上涨5.41%。本周，亚宝药业8月3日盘中最高价报6.97元。亚宝药业当前最新总市值47.19亿元，在中药板块市值排名44/66，在两市A股市值排名3268/5205。本周关注点公司公告汇总：亚宝药业拟以1亿至2亿元自有资金回购股份，回购价不超6.95元/股。公司公告汇总亚宝药业集团股份有限公司于2026年7月31日召开第十届董事会第二次会议，审议通过《关于以集中竞价交易方式回购股份方案的议案》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0028","BK0077","BK0201","600351","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657302681","title":"亚宝药业（600351）披露2026年中期利润分配及股份回购预案，8月6日股价下跌1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657302681","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657302681?lang=zh_cn&edition=full","pubTime":"2026-08-06 17:28","pubTimestamp":1786008511,"startTime":"0","endTime":"0","summary":"截至2026年8月6日收盘，亚宝药业报收于6.66元，较前一交易日下跌1.48%，最新总市值为46.09亿元。该股当日开盘6.73元，最高6.75元，最低6.61元，成交额达1.7亿元，换手率为3.69%。近日，亚宝药业集团股份有限公司披露2026年第三次临时股东会会议资料，审议2026年中期利润分配方案及以集中竞价交易方式回购股份的议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600028813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0028","BK0096","BK0201","BK0239","600351"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657524593","title":"股市必读：亚宝药业新发布《亚宝药业集团股份有限公司关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657524593","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657524593?lang=zh_cn&edition=full","pubTime":"2026-08-06 02:10","pubTimestamp":1785953423,"startTime":"0","endTime":"0","summary":"截至2026年8月5日收盘，亚宝药业报收于6.76元，下跌1.74%，换手率4.93%，成交量34.14万手，成交额2.3亿元。公司公告汇总亚宝药业集团股份有限公司关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告亚宝药业集团股份有限公司于2026年7月31日召开第十届董事会第二次会议，审议通过《关于以集中竞价交易方式回购股份方案的议案》。山西亚宝投资集团有限公司持股94,300,000股，占比13.63%，为第一大股东。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600001799.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600351","BK0096","BK0028","BK0077","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656953434","title":"亚宝药业（600351）披露回购股份事项前十名股东持股情况，8月4日股价下跌0.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656953434","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656953434?lang=zh_cn&edition=full","pubTime":"2026-08-04 17:57","pubTimestamp":1785837455,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，亚宝药业报收于6.88元，较前一交易日下跌0.43%，最新总市值为47.61亿元。该股当日开盘6.85元，最高6.95元，最低6.78元，成交额达2.94亿元，换手率为6.2%。近日，亚宝药业集团股份有限公司发布《关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告》。公司前十名股东与前十名无限售条件股东名单一致，因公司现有股份均为无限售条件流通股。山西亚宝投资集团有限公司持股94,300,000股，占比13.63%，为第一大股东。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400030375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0201","BK0239","BK0077","600351","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656324584","title":"8月3日亚宝药业涨6.80%，华富匠心明选一年持有混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2656324584","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656324584?lang=zh_cn&edition=full","pubTime":"2026-08-03 16:34","pubTimestamp":1785746097,"startTime":"0","endTime":"0","summary":"证券之星消息，8月3日亚宝药业涨6.80%创60日新高，收盘报6.91元，换手率8.27%，成交量57.2万手，成交额3.92亿元。重仓亚宝药业的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为华富基金的华富匠心明选一年持有混合A。华富匠心明选一年持有混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300021394.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","BK0096","BK0028","BK0077","600351"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656324311","title":"亚宝药业（600351）2026年中报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2656324311","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656324311?lang=zh_cn&edition=full","pubTime":"2026-08-02 06:01","pubTimestamp":1785621661,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期亚宝药业发布2026年中报。截至本报告期末，公司营业总收入11.45亿元，同比上升0.49%，归母净利润1.78亿元，同比上升1.83%。本报告期亚宝药业盈利能力上升，毛利率同比增幅2.72%，净利率同比增幅1.81%。持有亚宝药业最多的基金为华富匠心明选一年持有混合A，目前规模为0.23亿元，最新净值0.8724，较上一交易日上涨0.09%，近一年上涨0.29%。本文数据来源于亚宝药业2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080200001241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600351"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656161683","title":"每周股票复盘：亚宝药业（600351）Q2收入增9.15%，拟每10股派2元","url":"https://stock-news.laohu8.com/highlight/detail?id=2656161683","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656161683?lang=zh_cn&edition=full","pubTime":"2026-08-02 02:10","pubTimestamp":1785607822,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，亚宝药业报收于6.47元，较上周的6.41元上涨0.94%。本周，亚宝药业7月28日盘中最高价报6.62元。户均持股数量由1.35万股升至1.45万股，户均持股市值为8.32万元。回购股份将用于注销并减少注册资本。公司拟向全资子公司北京亚宝生物药业有限公司增资1亿元，注册资本由8,000万元增至1.8亿元；向山西亚宝医药物流配送有限公司增资5,000万元，注册资本由5,000万元增至1亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080200000526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0239","600351","BK0028","BK0201","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655035499","title":"亚宝药业(600351)6月30日股东户数4.78万户，较上期减少6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655035499","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655035499?lang=zh_cn&edition=full","pubTime":"2026-07-31 17:37","pubTimestamp":1785490671,"startTime":"0","endTime":"0","summary":"证券之星消息，近日亚宝药业披露，截至2026年6月30日公司股东户数为4.78万户，较3月31日减少3307.0户，减幅为6.47%。在中药行业个股中，亚宝药业股东户数低于行业平均水平，截至6月30日，中药行业平均股东户数为5.38万户。从股价来看，2026年3月31日至2026年6月30日，亚宝药业区间跌幅为11.69%，在此期间股东户数减少3307.0户，减幅为6.47%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100029520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0077","600351","BK0201","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655354370","title":"亚宝药业最新公告：全资子公司获盐酸左西替利嗪口服溶液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2655354370","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655354370?lang=zh_cn&edition=full","pubTime":"2026-07-31 17:29","pubTimestamp":1785490157,"startTime":"0","endTime":"0","summary":"亚宝药业(600351.SH)公告称，公司全资子公司亚宝药业四川制药有限公司收到国家药监局核准签发的盐酸左西替利嗪口服溶液两个规格《药品注册证书》。该药品适用于过敏性鼻炎、慢性特发性荨麻疹等抗过敏治疗，2025年国内销售金额为4.61亿元。公司已投入研发费用500.6万元。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100029054.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0077","600351","BK0201","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655355145","title":"亚宝药业(600351.SH)拟1亿元至2亿元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2655355145","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655355145?lang=zh_cn&edition=full","pubTime":"2026-07-31 16:01","pubTimestamp":1785484883,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亚宝药业(600351.SH)发布公告，公司拟1亿元至2亿元回购股份，回购股份价格不超过6.95元/股，回购股份将依法全部予以注销并减少公司注册资本。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1474562.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亚宝药业(600351.SH)拟1亿元至2亿元回购股份","news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0096","BK0077","600351","BK0201","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649692754","title":"每周股票复盘：亚宝药业（600351）获克立硼罗软膏注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2649692754","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649692754?lang=zh_cn&edition=full","pubTime":"2026-07-05 04:31","pubTimestamp":1783197071,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，亚宝药业报收于6.2元，较上周的5.7元上涨8.77%。本周，亚宝药业7月3日盘中最高价报6.21元。本周关注点公司公告汇总：亚宝药业取得克立硼罗软膏药品注册证书，拓展皮肤科产品线。公司公告汇总亚宝药业集团股份有限公司近日收到国家药品监督管理局核准签发的克立硼罗软膏《药品注册证书》，药品批准文号为国药准字H20264993，注册分类为化学药品4类。截至公告日，国内共有21家企业获得该药品注册批文。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500001624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0077","BK0201","600351","BK0239","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648057767","title":"亚宝药业(600351.SH)：取得克立硼罗软膏药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2648057767","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648057767?lang=zh_cn&edition=full","pubTime":"2026-07-02 15:38","pubTimestamp":1782977895,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亚宝药业(600351.SH)发布公告，近日，公司收到了国家药品监督管理局核准签发的克立硼罗软膏《药品注册证书》。克立硼罗软膏适用于3月龄及以上轻度至中度特应性皮炎患者的局部外用治疗。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462267.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亚宝药业(600351.SH)：取得克立硼罗软膏药品注册证书","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0096","BK0239","600351","BK0028","BK0201","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646130423","title":"每周股票复盘：亚宝药业（600351）东莨菪碱透皮贴片获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2646130423","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646130423?lang=zh_cn&edition=full","pubTime":"2026-06-28 02:54","pubTimestamp":1782586450,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，亚宝药业报收于5.7元，较上周的5.98元下跌4.68%。本周，亚宝药业6月23日盘中最高价报6.21元。本周关注点公司公告汇总：东莨菪碱透皮贴片获药物临床试验批准通知书。公司公告汇总亚宝药业集团股份有限公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，同意公司东莨菪碱透皮贴片开展临床试验。截至目前，公司已投入研发费用约3017.39万元人民币。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800000794.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0201","BK0096","600351","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646820148","title":"亚宝药业(600351.SH)：东莨菪碱透皮贴片获批开展临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2646820148","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646820148?lang=zh_cn&edition=full","pubTime":"2026-06-25 15:37","pubTimestamp":1782373053,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亚宝药业(600351.SH)发布公告，近日，公司收到了国家药品监督管理局核准签发的东莨菪碱透皮贴片的《药物临床试验批准通知书》。该药物的适应症为预防与麻醉和/或阿片镇痛和手术恢复相关的术后恶心和呕吐。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1458612.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0201","BK0239","600351","BK0096","BK0077"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787012507763,"stockEarnings":[{"period":"1week","weight":0.0287},{"period":"1month","weight":0.0915},{"period":"3month","weight":0.113},{"period":"6month","weight":0.108},{"period":"1year","weight":0.0155},{"period":"ytd","weight":0.1642}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.058},{"period":"3month","weight":-0.0448},{"period":"6month","weight":-0.0244},{"period":"1year","weight":0.0773},{"period":"ytd","weight":0.0035}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"亚宝药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"47810人(较上一季度减少6.47%)","perCapita":"14473股","listingDate":"2002-09-26","address":"山西省运城市芮城县富民路43号","registeredCapital":"69200万元","survey":" 亚宝药业集团股份有限公司的主营业务是药品及大健康产品的研发、生产和销售。公司的主要产品是丁桂儿脐贴、薏芽健脾凝胶、儿童清咽解热口服液、甲钴胺片、盐酸倍他司汀注射液、红花注射液、硝苯地平缓释片、唯源素、唯源泰、唯源全。","listedPrice":4.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"亚宝药业(600351)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供亚宝药业(600351)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"亚宝药业,600351,亚宝药业股票,亚宝药业股票老虎,亚宝药业股票老虎国际,亚宝药业行情,亚宝药业股票行情,亚宝药业股价,亚宝药业股市,亚宝药业股票价格,亚宝药业股票交易,亚宝药业股票购买,亚宝药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"亚宝药业(600351)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供亚宝药业(600351)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}